To every one of you walking this path — whether you’re fighting, supporting someone you love, researching late at night, or simply trying to hold things together — I want you to know how deeply respected you are. This journey is not easy. It takes courage, resilience, curiosity, and heart. And yet, despite everything, this community continues to show up with generosity, wisdom, and care for one another. That matters more than words can express. Christmas can bring joy, but it can also bring reflection, uncertainty, and mixed emotions — and all of that is okay. Wherever you find yourself today, please know you’re not alone. Wishing you peace, moments of warmth, and renewed hope as we move toward a new year together 💚

Hey Warriors 🙂, I’ve been a bit quieter lately as we’ve been working behind the scenes on something important: My mum completed the Astron Health multi-omic analysis, and the results have finally arrived. Next week we meet Astron’s integrative oncologist to go through the full interpretation — but I want to share the key insights now, because this is something that can empower every person in this community. ⭐ What Astron Revealed About My Mum’s Cancer Her tumour is not random. It runs on specific biological pathways — almost like an engine with identifiable components. The major drivers they identified were: 🔥 FGFR2 → MAPK (Main Growth Engine) 🔥 VEGF / Angiogenesis (Blood Supply) 🔥 MMP15 (Invasion + Tissue Breakdown) 🔥 WNT Signalling (Stem-Cell Survival + Recurrence) 🔥 FANCA Mutation (DNA-Repair Weakness → ROS Sensitivity) And important update: ➡️ CTCs were only 2, which is very low and extremely reassuring. ⭐ This Report Was NOT Essential — But It Was Incredibly Helpful I want to make something clear to everyone: You do NOT need expensive molecular testing to build an effective, multi-pathway protocol. Over the past 1.5 years, I created my mum’s protocol by studying: - cancer signalling pathways - metabolic vulnerabilities - invasion markers - angiogenesis mechanisms - mitochondrial weaknesses - stem-cell biology And what shocked me was this: The Astron findings matched almost exactly what I had already built through research alone. This is HUGE for this community. It proves that: ✔ you can learn what drives your cancer ✔ you can build precision strategies without testing ✔ you can target the actual pathways behind the disease ✔ you do NOT need to shoot in the dark The report confirmed the work — it didn’t create it. ⭐ The One Pathway We Had Not Fully Targeted: RAS → MAPK Astron’s report highlighted one important component: Atorvastatin This inhibits RAS prenylation, which is the top upstream switch that activates the MAPK pathway — the main engine of her tumour.

Hey Warriors, I wanted to share an honest update about my mum’s latest scan and what I’ve learned through this process — I hope it helps others make more informed decisions. Unfortunately, my mum’s recent PET scan results weren’t good. For context, the previous scan in June showed a mixed response with one new lesion appearing. Because of financial constraints, we stopped IV Vitamin C and HBOT about four months ago, and I had planned to strengthen her protocol with additional off-label therapies — Low Dose Naltrexone (LDN), Doxycycline, Hydroxychloroquine, and Niclosamide — all discussed in Jane McLelland’s book How to Starve Cancer. My mum completed the 3-month Orthomolecular protocol back in June and that’s when we saw positive but mixed results. At the time, my mum had strong faith in the NHS oncologists and their plan with immunotherapy (Keytruda). They weren’t sure if the June scan reflected pseudoprogression or inflammation, and even though the radiologist advised a CT scan for clarification, the oncologists decided to wait until the next PET scan. Sadly, that delay cost us valuable time. The latest scan now shows more lesions, and we were told now that SRS/Gamma Knife is no longer an option. The oncologist’s words were: “It’s too late for that.” Also CA125 jumped from 395 to 1100 in 3/4 months. The NHS is an incredible resource in many ways, especially because it funds chemotherapy and immunotherapy, but most NHS doctors have little or no understanding of metabolic therapy. They tend to dismiss it or even speak negatively about it. I printed out research papers and handed them directly to the team, but they ignored them completely. My mum followed their advice because she trusted them, which is understandable, but this experience has changed her perspective. Now she wants to move forward under integrative expert guidance, possibly through Astron Health or a similar precision-medicine approach. From Jane McLelland’s book, I learned that adenocarcinomas (like my mum’s) are generally glutamine-driven, meaning they rely heavily on glutamine as a primary fuel source. We target glutamine in several ways — through fasting and exercise simultaneously, which deplete available fuel, and more importantly through the use of specific off-label drugs. One of the most powerful glutamine antagonists is DON (6-diazo-5-oxo-L-norleucine), though it’s out of reach for most of us due to limited access and high cost. That’s why it’s crucial to investigate or implement other off-labels that can impact glutamine metabolism indirectly. This is also where diet becomes strategic: a pescatarian approach, as Jane suggests, or a vegan keto diet during the kill phase makes a lot of sense for targeting both glutamine and methionine metabolism simultaneously.

..my beloved fellow travelers, I am a carb-addict (BIG TIME) ha-ha! => So I found Dr. Robert Cywes, MD, PhD, YT channel => he's a #CarbAddictionDoc. I've kept in my helpful quote piggy bank: "𝙀𝙫𝙚𝙧𝙮 𝙨𝙣𝙖𝙘𝙠 𝙞𝙨 𝙖𝙣 𝙚𝙢𝙤𝙩𝙞𝙤𝙣𝙖𝙡 𝙚𝙫𝙚𝙣𝙩," and this is so true for me => it has been handy. He gives many tips, and I thought, maybe there is someone in the same boat as me? He's all in for keto! Bonus: he is one of the participants in the animal documentary that @Lemon P graciously shared with us.. P.S. Here comes another quote: "𝙈𝙚𝙧𝙚 𝙖𝙘𝙠𝙣𝙤𝙬𝙡𝙚𝙙𝙜𝙚𝙢𝙚𝙣𝙩 𝙤𝙛 𝙩𝙝𝙚 𝙥𝙧𝙤𝙗𝙡𝙚𝙢 𝙝𝙚𝙡𝙥𝙨 𝙩𝙤 𝙨𝙤𝙡𝙫𝙚 𝙞𝙩.". ~ Martyn Lloyd-Jones

Today marks a huge step for our mission — the first episode of the Cancer Warriors Podcast is officially live on YouTube! This series shares real stories of hope and science, exploring how people are using metabolic therapy and repurposed drugs in their healing journeys. The goal is simple: to give a voice to those on the frontlines — patients, caregivers, and scientists — and to keep spreading the message about metabolic therapy. Please like, comment, and share if this episode resonates with you — it helps the algorithm reach more Warriors who need hope and this information. https://youtu.be/lVoFRSvPD_Q?si=1ZxFqPdQ6MW4jhFP